Anesth Analg 2001;92:855-862
© 2001 International Anesthesia Research Society
CARDIOVASCULAR ANESTHESIA
Voluven®, a Lower Substituted Novel Hydroxyethyl Starch (HES 130/0.4), Causes Fewer Effects on Coagulation in Major Orthopedic Surgery than HES 200/0.5
Olivier Langeron, MD*,
Martin Doelberg, PhD ,
Eng-Than Ang, MD ,
Francis Bonnet, MD§,
Xavier Capdevila, MD, PhD||, and
Pierre Coriat, MD*
*Département dAnesthésie-Réanimation, Centre Hospitalo-universitaire (CHU) Pitié-Salpêtrière, Paris, France; Fresenius Kabi, Fluid Therapy Division, Bad Homburg, Germany; Département dAnesthésie-Réanimation, Centre Hospitalo-universitaire (CHU) Beaujon, Clichy, France; §Département dAnesthésie-Réanimation, Centre Hospitalo-universitaire (CHU) Tenon, Paris, France; ||Département dAnesthésie-Réanimation, Centre Hospitalo-universitaire (CHU) Lapeyronie, Montpellier, France
Address correspondence and reprint requests to O. Langeron, MD, Département dAnesthésie-Réanimation, Groupe Hospitalier Pitié-Salpêtrière, 47 Boulevard de lHôpital, 75651 Paris Cédex 13, France. Address e-mail to olivier.langeron{at}psl.ap-hop-paris.fr
Hydroxyethyl starch (HES) solutions are effective plasma volume expanders. Impairment of coagulation occurs with large HES volumes infused perioperatively. Therefore, a lower substituted novel HES (Voluven®; Fresenius Kabi, Bad Homburg, Germany) was developed to minimize hemostatic interactions, and was compared with HAES-steril® (Fresenius Kabi) (pentastarch) regarding safety and efficacy. We performed a prospective, randomized, double-blinded study in 100 major orthopedic surgery patients. Because the 95% confidence interval (-330 mL; +284 mL) for the treatment contrast Voluven®-HAES-steril® was entirely included in the predefined equivalence range (± 500 mL), comparable efficacy was established. Voluven® interfered significantly less than HAES-steril® with coagulation factor VIII levels and partial thromboplastin time postoperatively. Total amounts of red blood cells transfused were comparable between the Voluven® and HAES-steril® groups, but a significantly reduced need for homologous red blood cells was observed in the Voluven® group. We conclude that in large-bloodloss surgery, Voluven® has a comparable efficacy with HAES-steril® and may reduce coagulation impairment, possibly leading to a smaller number of allogeneic blood transfusions.
Implications: Hydroxyethyl starches are common plasma volume expanders, but may interfere with coagulation at large doses. We tested a novel hydroxyethyl starch specification (Voluven®; Fresenius Kabi, Bad Homburg, Germany) which was developed to reduce hemostatic interactions while preserving its efficacy in restoring plasma volume in comparison to HAES-steril® (pentastarch; Fresenius Kabi) in major orthopedic surgery.
This article has been cited by other articles:

|
 |

|
 |
 
S. A. Kozek-Langenecker, C. Jungheinrich, W. Sauermann, and P. van der Linden
Hydroxyethyl Starch 130/0.4 and Surgical Blood Loss
Anesth. Analg.,
February 1, 2009;
108(2):
672 - 673.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. A. Schramko, R. T. Suojaranta-Ylinen, A. H. Kuitunen, S. I. Kukkonen, and T. T. Niemi
Rapidly Degradable Hydroxyethyl Starch Solutions Impair Blood Coagulation After Cardiac Surgery: A Prospective Randomized Trial
Anesth. Analg.,
January 1, 2009;
108(1):
30 - 36.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. A. Kozek-Langenecker, C. Jungheinrich, W. Sauermann, and P. Van der Linden
The Effects of Hydroxyethyl Starch 130/0.4 (6%) on Blood Loss and Use of Blood Products in Major Surgery: A Pooled Analysis of Randomized Clinical Trials
Anesth. Analg.,
August 1, 2008;
107(2):
382 - 390.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Blasco, M. Leone, F. Antonini, A. Geissler, J. Albanese, and C. Martin
Comparison of the novel hydroxyethylstarch 130/0.4 and hydroxyethylstarch 200/0.6 in brain-dead donor resuscitation on renal function after transplantation
Br. J. Anaesth.,
April 1, 2008;
100(4):
504 - 508.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Hitosugi, T. Saito, S. Suzuki, I. Kubota, E. Shoda, T. Shimizu, and Y. Oi
Hydroxyethyl Starch: The Effect of Molecular Weight and Degree of Substitution on Intravascular Retention In Vivo
Anesth. Analg.,
September 1, 2007;
105(3):
724 - 728.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. H. Mills
Hydroxyethyl starch: does our choice of colloid prevent or add to renal impairment?
Br. J. Anaesth.,
February 1, 2007;
98(2):
157 - 159.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Boldt, M. Wolf, and A. Mengistu
A New Plasma-Adapted Hydroxyethylstarch Preparation: In Vitro Coagulation Studies Using Thrombelastography and Whole Blood Aggregometry
Anesth. Analg.,
February 1, 2007;
104(2):
425 - 430.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. G. Kang, H. J. Ahn, G. S. Kim, T. S. Hahm, J. J. Lee, M. S. Gwak, and S. J. Choi
The Hemostatic Profiles of Patients with Type O and Non-O Blood After Acute Normovolemic Hemodilution with 6% Hydroxyethyl Starch (130/0.4)
Anesth. Analg.,
December 1, 2006;
103(6):
1543 - 1548.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. von Roten, C. Madjdpour, P. Frascarolo, M.-A. Burmeister, A. Fisch, S. Schramm, T. Bombeli, and D. R. Spahn
Molar substitution and C2/C6 ratio of hydroxyethyl starch: influence on blood coagulation
Br. J. Anaesth.,
April 1, 2006;
96(4):
455 - 463.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. De Lorenzo, A. Calatzis, U. Welsch, and B. Heindl
Fibrinogen concentrate reverses dilutional coagulopathy induced in vitro by saline but not by hydroxyethyl starch 6%.
Anesth. Analg.,
April 1, 2006;
102(4):
1194 - 1200.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. K. Unger, C. Haltern, B. Dohmen, A. Gressner, C. Grosse-Siestrup, D. A. Groneberg, and R. Rossaint
Albumin and hydroxyethyl starch 130 kDa/0.4 improve filter clearance and haemocompatibility in haemo- and plasmafiltration--an in vitro study
Nephrol. Dial. Transplant.,
September 1, 2005;
20(9):
1922 - 1931.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. J. Van der Linden, S. G. De Hert, D. Deraedt, S. Cromheecke, K. De Decker, R. D. Paep, I. Rodrigus, A. Daper, and A. Trenchant
Hydroxyethyl Starch 130/0.4 Versus Modified Fluid Gelatin for Volume Expansion in Cardiac Surgery Patients: The Effects on Perioperative Bleeding and Transfusion Needs
Anesth. Analg.,
September 1, 2005;
101(3):
629 - 634.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Arellano, B. S. Gan, M. J. Salpeter, E. Yeo, S. McCluskey, R. Pinto, J. Irish, D. C. Ross, D. J. Doyle, J. Parkin, et al.
A Triple-Blinded Randomized Trial Comparing the Hemostatic Effects of Large-Dose 10% Hydroxyethyl Starch 264/0.45 Versus 5% Albumin During Major Reconstructive Surgery
Anesth. Analg.,
June 1, 2005;
100(6):
1846 - 1853.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Madjdpour, N. Dettori, P. Frascarolo, M. Burki, M. Boll, A. Fisch, T. Bombeli, and D. R. Spahn
Molecular weight of hydroxyethyl starch: is there an effect on blood coagulation and pharmacokinetics?
Br. J. Anaesth.,
May 1, 2005;
94(5):
569 - 576.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. P. W. Grocott, M. G. Mythen, and T. J. Gan
Perioperative Fluid Management and Clinical Outcomes in Adults
Anesth. Analg.,
April 1, 2005;
100(4):
1093 - 1106.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Fenger-Eriksen, E. Anker-Moller, J. Heslop, J. Ingerslev, and B. Sorensen
Thrombelastographic whole blood clot formation after ex vivo addition of plasma substitutes: improvements of the induced coagulopathy with fibrinogen concentrate
Br. J. Anaesth.,
March 1, 2005;
94(3):
324 - 329.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. H. Kuitunen, M. J. Hynynen, E. Vahtera, and M. T. Salmenpera
Hydroxyethyl Starch as a Priming Solution for Cardiopulmonary Bypass Impairs Hemostasis After Cardiac Surgery
Anesth. Analg.,
February 1, 2004;
98(2):
291 - 297.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Boldt
New Light on Intravascular Volume Replacement Regimens: What Did We Learn from the Past Three Years?
Anesth. Analg.,
December 1, 2003;
97(6):
1595 - 1604.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. E. Ickx, F. Bepperling, C. Melot, C. Schulman, and P. J. Van der Linden
Plasma substitution effects of a new hydroxyethyl starch HES 130/0.4 compared with HES 200/0.5 during and after extended acute normovolaemic haemodilution
Br. J. Anaesth.,
August 1, 2003;
91(2):
196 - 202.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. A. Neff, M. Doelberg, C. Jungheinrich, A. Sauerland, D. R. Spahn, and R. Stocker
Repetitive Large-Dose Infusion of the Novel Hydroxyethyl Starch 130/0.4 in Patients with Severe Head Injury
Anesth. Analg.,
May 1, 2003;
96(5):
1453 - 1459.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Standl, M.-A. Burmeister, F. Schroeder, E. Currlin, J. Schulte am Esch, M. Freitag, and J. Schulte am Esch
Hydroxyethyl Starch (HES) 130/0.4 Provides Larger and Faster Increases in Tissue Oxygen Tension in Comparison with Prehemodilution Values than HES 70/0.5 or HES 200/0.5 in Volunteers Undergoing Acute Normovolemic Hemodilution
Anesth. Analg.,
April 1, 2003;
96(4):
936 - 943.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Boldt, G. Haisch, S. Suttner, B. Kumle, and A. Schellhaass
Effects of a new modified, balanced hydroxyethyl starch preparation (Hextend(R)) on measures of coagulation
Br. J. Anaesth.,
November 1, 2002;
89(5):
722 - 728.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Jungheinrich, R. Scharpf, M. Wargenau, F. Bepperling, and J.-F. Baron
The Pharmacokinetics and Tolerability of an Intravenous Infusion of the New Hydroxyethyl Starch 130/0.4 (6%, 500 mL) in Mild-to-Severe Renal Impairment
Anesth. Analg.,
September 1, 2002;
95(3):
544 - 551.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Fries, P. Innerhofer, A. Klingler, U. Berresheim, M. Mittermayr, A. Calatzis, and W. Schobersberger
The Effect of the Combined Administration of Colloids and Lactated Ringer's Solution on the Coagulation System: An In Vitro Study Using Thrombelastograph(R) Coagulation Analysis (ROTEG(R))
Anesth. Analg.,
May 1, 2002;
94(5):
1280 - 1287.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|